ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Subcutaneous Vaccine Adjuvants Market Research Report 2025
Published Date: January 2025
|
Report Code: QYRE-Auto-37N13166
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Subcutaneous Vaccine Adjuvants Market Research Report 2023
BUY CHAPTERS

Global Subcutaneous Vaccine Adjuvants Market Research Report 2025

Code: QYRE-Auto-37N13166
Report
January 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Agenus
Croda International
SEPPIC
Oz Biosciences
Phibro Animal Health
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited
GSK
Dynavax Technologies
Novavax Inc

Subcutaneous Vaccine Adjuvants Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Subcutaneous Vaccine Adjuvants Market

Subcutaneous Vaccine Adjuvants Market

The global market for Subcutaneous Vaccine Adjuvants was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Subcutaneous Vaccine Adjuvants is used for Subcutaneous injection of Vaccine Adjuvants. A vaccine adjuvant is any material which is incorporated with a vaccine for the purpose of enhancing the immune response of the vaccine. An adjuvanted vaccine will tend to have a higher, earlier, and longer-lasting immune response than a non-adjuvanted vaccine.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Subcutaneous Vaccine Adjuvants, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Subcutaneous Vaccine Adjuvants.
The Subcutaneous Vaccine Adjuvants market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Subcutaneous Vaccine Adjuvants market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Subcutaneous Vaccine Adjuvants manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Subcutaneous Vaccine Adjuvants Market Report

Report Metric Details
Report Name Subcutaneous Vaccine Adjuvants Market
CAGR 5%
Segment by Type
Segment by Application
  • Research Applications
  • Commercial Applications
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Agenus, Croda International, Seppic, OZ Biosciences, Phibro Animal Health, Associated British Foods, InvivoGen, Merck KGaA, CSL Limited, GSK, Dynavax Technologies, Novavax
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Subcutaneous Vaccine Adjuvants manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Subcutaneous Vaccine Adjuvants in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Subcutaneous Vaccine Adjuvants Market report?

Ans: The main players in the Subcutaneous Vaccine Adjuvants Market are Agenus, Croda International, Seppic, OZ Biosciences, Phibro Animal Health, Associated British Foods, InvivoGen, Merck KGaA, CSL Limited, GSK, Dynavax Technologies, Novavax

What are the Application segmentation covered in the Subcutaneous Vaccine Adjuvants Market report?

Ans: The Applications covered in the Subcutaneous Vaccine Adjuvants Market report are Research Applications, Commercial Applications

What are the Type segmentation covered in the Subcutaneous Vaccine Adjuvants Market report?

Ans: The Types covered in the Subcutaneous Vaccine Adjuvants Market report are Infectious Diseases, Cancer, Others

Recommended Reports

Vaccine Technologies

Pediatric & Flu Vaccines

Vaccine Logistics & Packaging

1 Subcutaneous Vaccine Adjuvants Market Overview
1.1 Product Definition
1.2 Subcutaneous Vaccine Adjuvants by Type
1.2.1 Global Subcutaneous Vaccine Adjuvants Market Value Comparison by Type (2024 VS 2031)
1.2.2 Infectious Diseases
1.2.3 Cancer
1.2.4 Others
1.3 Subcutaneous Vaccine Adjuvants by Application
1.3.1 Global Subcutaneous Vaccine Adjuvants Market Value by Application (2024 VS 2031)
1.3.2 Research Applications
1.3.3 Commercial Applications
1.4 Global Subcutaneous Vaccine Adjuvants Market Size Estimates and Forecasts
1.4.1 Global Subcutaneous Vaccine Adjuvants Revenue 2020-2031
1.4.2 Global Subcutaneous Vaccine Adjuvants Sales 2020-2031
1.4.3 Global Subcutaneous Vaccine Adjuvants Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Subcutaneous Vaccine Adjuvants Market Competition by Manufacturers
2.1 Global Subcutaneous Vaccine Adjuvants Sales Market Share by Manufacturers (2020-2025)
2.2 Global Subcutaneous Vaccine Adjuvants Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Subcutaneous Vaccine Adjuvants Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Subcutaneous Vaccine Adjuvants, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Subcutaneous Vaccine Adjuvants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Subcutaneous Vaccine Adjuvants, Product Type & Application
2.7 Global Key Manufacturers of Subcutaneous Vaccine Adjuvants, Date of Enter into This Industry
2.8 Global Subcutaneous Vaccine Adjuvants Market Competitive Situation and Trends
2.8.1 Global Subcutaneous Vaccine Adjuvants Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Subcutaneous Vaccine Adjuvants Players Market Share by Revenue
2.8.3 Global Subcutaneous Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Subcutaneous Vaccine Adjuvants Market Scenario by Region
3.1 Global Subcutaneous Vaccine Adjuvants Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Subcutaneous Vaccine Adjuvants Sales by Region: 2020-2031
3.2.1 Global Subcutaneous Vaccine Adjuvants Sales by Region: 2020-2025
3.2.2 Global Subcutaneous Vaccine Adjuvants Sales by Region: 2026-2031
3.3 Global Subcutaneous Vaccine Adjuvants Revenue by Region: 2020-2031
3.3.1 Global Subcutaneous Vaccine Adjuvants Revenue by Region: 2020-2025
3.3.2 Global Subcutaneous Vaccine Adjuvants Revenue by Region: 2026-2031
3.4 North America Subcutaneous Vaccine Adjuvants Market Facts & Figures by Country
3.4.1 North America Subcutaneous Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Subcutaneous Vaccine Adjuvants Sales by Country (2020-2031)
3.4.3 North America Subcutaneous Vaccine Adjuvants Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Subcutaneous Vaccine Adjuvants Market Facts & Figures by Country
3.5.1 Europe Subcutaneous Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Subcutaneous Vaccine Adjuvants Sales by Country (2020-2031)
3.5.3 Europe Subcutaneous Vaccine Adjuvants Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Subcutaneous Vaccine Adjuvants Market Facts & Figures by Region
3.6.1 Asia Pacific Subcutaneous Vaccine Adjuvants Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Subcutaneous Vaccine Adjuvants Sales by Region (2020-2031)
3.6.3 Asia Pacific Subcutaneous Vaccine Adjuvants Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Subcutaneous Vaccine Adjuvants Market Facts & Figures by Country
3.7.1 Latin America Subcutaneous Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Subcutaneous Vaccine Adjuvants Sales by Country (2020-2031)
3.7.3 Latin America Subcutaneous Vaccine Adjuvants Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Subcutaneous Vaccine Adjuvants Market Facts & Figures by Country
3.8.1 Middle East and Africa Subcutaneous Vaccine Adjuvants Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Subcutaneous Vaccine Adjuvants Sales by Country (2020-2031)
3.8.3 Middle East and Africa Subcutaneous Vaccine Adjuvants Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Subcutaneous Vaccine Adjuvants Sales by Type (2020-2031)
4.1.1 Global Subcutaneous Vaccine Adjuvants Sales by Type (2020-2025)
4.1.2 Global Subcutaneous Vaccine Adjuvants Sales by Type (2026-2031)
4.1.3 Global Subcutaneous Vaccine Adjuvants Sales Market Share by Type (2020-2031)
4.2 Global Subcutaneous Vaccine Adjuvants Revenue by Type (2020-2031)
4.2.1 Global Subcutaneous Vaccine Adjuvants Revenue by Type (2020-2025)
4.2.2 Global Subcutaneous Vaccine Adjuvants Revenue by Type (2026-2031)
4.2.3 Global Subcutaneous Vaccine Adjuvants Revenue Market Share by Type (2020-2031)
4.3 Global Subcutaneous Vaccine Adjuvants Price by Type (2020-2031)
5 Segment by Application
5.1 Global Subcutaneous Vaccine Adjuvants Sales by Application (2020-2031)
5.1.1 Global Subcutaneous Vaccine Adjuvants Sales by Application (2020-2025)
5.1.2 Global Subcutaneous Vaccine Adjuvants Sales by Application (2026-2031)
5.1.3 Global Subcutaneous Vaccine Adjuvants Sales Market Share by Application (2020-2031)
5.2 Global Subcutaneous Vaccine Adjuvants Revenue by Application (2020-2031)
5.2.1 Global Subcutaneous Vaccine Adjuvants Revenue by Application (2020-2025)
5.2.2 Global Subcutaneous Vaccine Adjuvants Revenue by Application (2026-2031)
5.2.3 Global Subcutaneous Vaccine Adjuvants Revenue Market Share by Application (2020-2031)
5.3 Global Subcutaneous Vaccine Adjuvants Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Agenus
6.1.1 Agenus Company Information
6.1.2 Agenus Description and Business Overview
6.1.3 Agenus Subcutaneous Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Agenus Subcutaneous Vaccine Adjuvants Product Portfolio
6.1.5 Agenus Recent Developments/Updates
6.2 Croda International
6.2.1 Croda International Company Information
6.2.2 Croda International Description and Business Overview
6.2.3 Croda International Subcutaneous Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Croda International Subcutaneous Vaccine Adjuvants Product Portfolio
6.2.5 Croda International Recent Developments/Updates
6.3 Seppic
6.3.1 Seppic Company Information
6.3.2 Seppic Description and Business Overview
6.3.3 Seppic Subcutaneous Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Seppic Subcutaneous Vaccine Adjuvants Product Portfolio
6.3.5 Seppic Recent Developments/Updates
6.4 OZ Biosciences
6.4.1 OZ Biosciences Company Information
6.4.2 OZ Biosciences Description and Business Overview
6.4.3 OZ Biosciences Subcutaneous Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.4.4 OZ Biosciences Subcutaneous Vaccine Adjuvants Product Portfolio
6.4.5 OZ Biosciences Recent Developments/Updates
6.5 Phibro Animal Health
6.5.1 Phibro Animal Health Company Information
6.5.2 Phibro Animal Health Description and Business Overview
6.5.3 Phibro Animal Health Subcutaneous Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Phibro Animal Health Subcutaneous Vaccine Adjuvants Product Portfolio
6.5.5 Phibro Animal Health Recent Developments/Updates
6.6 Associated British Foods
6.6.1 Associated British Foods Company Information
6.6.2 Associated British Foods Description and Business Overview
6.6.3 Associated British Foods Subcutaneous Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Associated British Foods Subcutaneous Vaccine Adjuvants Product Portfolio
6.6.5 Associated British Foods Recent Developments/Updates
6.7 InvivoGen
6.7.1 InvivoGen Company Information
6.7.2 InvivoGen Description and Business Overview
6.7.3 InvivoGen Subcutaneous Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.7.4 InvivoGen Subcutaneous Vaccine Adjuvants Product Portfolio
6.7.5 InvivoGen Recent Developments/Updates
6.8 Merck KGaA
6.8.1 Merck KGaA Company Information
6.8.2 Merck KGaA Description and Business Overview
6.8.3 Merck KGaA Subcutaneous Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Merck KGaA Subcutaneous Vaccine Adjuvants Product Portfolio
6.8.5 Merck KGaA Recent Developments/Updates
6.9 CSL Limited
6.9.1 CSL Limited Company Information
6.9.2 CSL Limited Description and Business Overview
6.9.3 CSL Limited Subcutaneous Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.9.4 CSL Limited Subcutaneous Vaccine Adjuvants Product Portfolio
6.9.5 CSL Limited Recent Developments/Updates
6.10 GSK
6.10.1 GSK Company Information
6.10.2 GSK Description and Business Overview
6.10.3 GSK Subcutaneous Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.10.4 GSK Subcutaneous Vaccine Adjuvants Product Portfolio
6.10.5 GSK Recent Developments/Updates
6.11 Dynavax Technologies
6.11.1 Dynavax Technologies Company Information
6.11.2 Dynavax Technologies Description and Business Overview
6.11.3 Dynavax Technologies Subcutaneous Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Dynavax Technologies Subcutaneous Vaccine Adjuvants Product Portfolio
6.11.5 Dynavax Technologies Recent Developments/Updates
6.12 Novavax
6.12.1 Novavax Company Information
6.12.2 Novavax Description and Business Overview
6.12.3 Novavax Subcutaneous Vaccine Adjuvants Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Novavax Subcutaneous Vaccine Adjuvants Product Portfolio
6.12.5 Novavax Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Subcutaneous Vaccine Adjuvants Industry Chain Analysis
7.2 Subcutaneous Vaccine Adjuvants Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Subcutaneous Vaccine Adjuvants Production Mode & Process Analysis
7.4 Subcutaneous Vaccine Adjuvants Sales and Marketing
7.4.1 Subcutaneous Vaccine Adjuvants Sales Channels
7.4.2 Subcutaneous Vaccine Adjuvants Distributors
7.5 Subcutaneous Vaccine Adjuvants Customer Analysis
8 Subcutaneous Vaccine Adjuvants Market Dynamics
8.1 Subcutaneous Vaccine Adjuvants Industry Trends
8.2 Subcutaneous Vaccine Adjuvants Market Drivers
8.3 Subcutaneous Vaccine Adjuvants Market Challenges
8.4 Subcutaneous Vaccine Adjuvants Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Agenus
Croda International
SEPPIC
Oz Biosciences
Phibro Animal Health
Associated British Foods
InvivoGen
Merck KGaA
CSL Limited
GSK
Dynavax Technologies
Novavax Inc
List of Tables
 Table 1. Global Subcutaneous Vaccine Adjuvants Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Subcutaneous Vaccine Adjuvants Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Subcutaneous Vaccine Adjuvants Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Subcutaneous Vaccine Adjuvants Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Subcutaneous Vaccine Adjuvants Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Subcutaneous Vaccine Adjuvants Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Subcutaneous Vaccine Adjuvants Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Subcutaneous Vaccine Adjuvants Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Subcutaneous Vaccine Adjuvants, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Subcutaneous Vaccine Adjuvants, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Subcutaneous Vaccine Adjuvants, Product Type & Application
 Table 12. Global Key Manufacturers of Subcutaneous Vaccine Adjuvants, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Subcutaneous Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Subcutaneous Vaccine Adjuvants as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Subcutaneous Vaccine Adjuvants Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Subcutaneous Vaccine Adjuvants Sales by Region (2020-2025) & (K Units)
 Table 18. Global Subcutaneous Vaccine Adjuvants Sales Market Share by Region (2020-2025)
 Table 19. Global Subcutaneous Vaccine Adjuvants Sales by Region (2026-2031) & (K Units)
 Table 20. Global Subcutaneous Vaccine Adjuvants Sales Market Share by Region (2026-2031)
 Table 21. Global Subcutaneous Vaccine Adjuvants Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Subcutaneous Vaccine Adjuvants Revenue Market Share by Region (2020-2025)
 Table 23. Global Subcutaneous Vaccine Adjuvants Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Subcutaneous Vaccine Adjuvants Revenue Market Share by Region (2026-2031)
 Table 25. North America Subcutaneous Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Subcutaneous Vaccine Adjuvants Sales by Country (2020-2025) & (K Units)
 Table 27. North America Subcutaneous Vaccine Adjuvants Sales by Country (2026-2031) & (K Units)
 Table 28. North America Subcutaneous Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Subcutaneous Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Subcutaneous Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Subcutaneous Vaccine Adjuvants Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Subcutaneous Vaccine Adjuvants Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Subcutaneous Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Subcutaneous Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Subcutaneous Vaccine Adjuvants Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Subcutaneous Vaccine Adjuvants Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Subcutaneous Vaccine Adjuvants Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Subcutaneous Vaccine Adjuvants Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Subcutaneous Vaccine Adjuvants Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Subcutaneous Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Subcutaneous Vaccine Adjuvants Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Subcutaneous Vaccine Adjuvants Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Subcutaneous Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Subcutaneous Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Subcutaneous Vaccine Adjuvants Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Subcutaneous Vaccine Adjuvants Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Subcutaneous Vaccine Adjuvants Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Subcutaneous Vaccine Adjuvants Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Subcutaneous Vaccine Adjuvants Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Subcutaneous Vaccine Adjuvants Sales (K Units) by Type (2020-2025)
 Table 51. Global Subcutaneous Vaccine Adjuvants Sales (K Units) by Type (2026-2031)
 Table 52. Global Subcutaneous Vaccine Adjuvants Sales Market Share by Type (2020-2025)
 Table 53. Global Subcutaneous Vaccine Adjuvants Sales Market Share by Type (2026-2031)
 Table 54. Global Subcutaneous Vaccine Adjuvants Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Subcutaneous Vaccine Adjuvants Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Subcutaneous Vaccine Adjuvants Revenue Market Share by Type (2020-2025)
 Table 57. Global Subcutaneous Vaccine Adjuvants Revenue Market Share by Type (2026-2031)
 Table 58. Global Subcutaneous Vaccine Adjuvants Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Subcutaneous Vaccine Adjuvants Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Subcutaneous Vaccine Adjuvants Sales (K Units) by Application (2020-2025)
 Table 61. Global Subcutaneous Vaccine Adjuvants Sales (K Units) by Application (2026-2031)
 Table 62. Global Subcutaneous Vaccine Adjuvants Sales Market Share by Application (2020-2025)
 Table 63. Global Subcutaneous Vaccine Adjuvants Sales Market Share by Application (2026-2031)
 Table 64. Global Subcutaneous Vaccine Adjuvants Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Subcutaneous Vaccine Adjuvants Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Subcutaneous Vaccine Adjuvants Revenue Market Share by Application (2020-2025)
 Table 67. Global Subcutaneous Vaccine Adjuvants Revenue Market Share by Application (2026-2031)
 Table 68. Global Subcutaneous Vaccine Adjuvants Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Subcutaneous Vaccine Adjuvants Price (US$/Unit) by Application (2026-2031)
 Table 70. Agenus Company Information
 Table 71. Agenus Description and Business Overview
 Table 72. Agenus Subcutaneous Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Agenus Subcutaneous Vaccine Adjuvants Product
 Table 74. Agenus Recent Developments/Updates
 Table 75. Croda International Company Information
 Table 76. Croda International Description and Business Overview
 Table 77. Croda International Subcutaneous Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Croda International Subcutaneous Vaccine Adjuvants Product
 Table 79. Croda International Recent Developments/Updates
 Table 80. Seppic Company Information
 Table 81. Seppic Description and Business Overview
 Table 82. Seppic Subcutaneous Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Seppic Subcutaneous Vaccine Adjuvants Product
 Table 84. Seppic Recent Developments/Updates
 Table 85. OZ Biosciences Company Information
 Table 86. OZ Biosciences Description and Business Overview
 Table 87. OZ Biosciences Subcutaneous Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. OZ Biosciences Subcutaneous Vaccine Adjuvants Product
 Table 89. OZ Biosciences Recent Developments/Updates
 Table 90. Phibro Animal Health Company Information
 Table 91. Phibro Animal Health Description and Business Overview
 Table 92. Phibro Animal Health Subcutaneous Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Phibro Animal Health Subcutaneous Vaccine Adjuvants Product
 Table 94. Phibro Animal Health Recent Developments/Updates
 Table 95. Associated British Foods Company Information
 Table 96. Associated British Foods Description and Business Overview
 Table 97. Associated British Foods Subcutaneous Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Associated British Foods Subcutaneous Vaccine Adjuvants Product
 Table 99. Associated British Foods Recent Developments/Updates
 Table 100. InvivoGen Company Information
 Table 101. InvivoGen Description and Business Overview
 Table 102. InvivoGen Subcutaneous Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. InvivoGen Subcutaneous Vaccine Adjuvants Product
 Table 104. InvivoGen Recent Developments/Updates
 Table 105. Merck KGaA Company Information
 Table 106. Merck KGaA Description and Business Overview
 Table 107. Merck KGaA Subcutaneous Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Merck KGaA Subcutaneous Vaccine Adjuvants Product
 Table 109. Merck KGaA Recent Developments/Updates
 Table 110. CSL Limited Company Information
 Table 111. CSL Limited Description and Business Overview
 Table 112. CSL Limited Subcutaneous Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. CSL Limited Subcutaneous Vaccine Adjuvants Product
 Table 114. CSL Limited Recent Developments/Updates
 Table 115. GSK Company Information
 Table 116. GSK Description and Business Overview
 Table 117. GSK Subcutaneous Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. GSK Subcutaneous Vaccine Adjuvants Product
 Table 119. GSK Recent Developments/Updates
 Table 120. Dynavax Technologies Company Information
 Table 121. Dynavax Technologies Description and Business Overview
 Table 122. Dynavax Technologies Subcutaneous Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Dynavax Technologies Subcutaneous Vaccine Adjuvants Product
 Table 124. Dynavax Technologies Recent Developments/Updates
 Table 125. Novavax Company Information
 Table 126. Novavax Description and Business Overview
 Table 127. Novavax Subcutaneous Vaccine Adjuvants Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Novavax Subcutaneous Vaccine Adjuvants Product
 Table 129. Novavax Recent Developments/Updates
 Table 130. Key Raw Materials Lists
 Table 131. Raw Materials Key Suppliers Lists
 Table 132. Subcutaneous Vaccine Adjuvants Distributors List
 Table 133. Subcutaneous Vaccine Adjuvants Customers List
 Table 134. Subcutaneous Vaccine Adjuvants Market Trends
 Table 135. Subcutaneous Vaccine Adjuvants Market Drivers
 Table 136. Subcutaneous Vaccine Adjuvants Market Challenges
 Table 137. Subcutaneous Vaccine Adjuvants Market Restraints
 Table 138. Research Programs/Design for This Report
 Table 139. Key Data Information from Secondary Sources
 Table 140. Key Data Information from Primary Sources
 Table 141. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Subcutaneous Vaccine Adjuvants
 Figure 2. Global Subcutaneous Vaccine Adjuvants Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Subcutaneous Vaccine Adjuvants Market Share by Type: 2024 & 2031
 Figure 4. Infectious Diseases Product Picture
 Figure 5. Cancer Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Subcutaneous Vaccine Adjuvants Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Subcutaneous Vaccine Adjuvants Market Share by Application: 2024 & 2031
 Figure 9. Research Applications
 Figure 10. Commercial Applications
 Figure 11. Global Subcutaneous Vaccine Adjuvants Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 12. Global Subcutaneous Vaccine Adjuvants Market Size (2020-2031) & (US$ Million)
 Figure 13. Global Subcutaneous Vaccine Adjuvants Sales (2020-2031) & (K Units)
 Figure 14. Global Subcutaneous Vaccine Adjuvants Average Price (US$/Unit) & (2020-2031)
 Figure 15. Subcutaneous Vaccine Adjuvants Report Years Considered
 Figure 16. Subcutaneous Vaccine Adjuvants Sales Share by Manufacturers in 2024
 Figure 17. Global Subcutaneous Vaccine Adjuvants Revenue Share by Manufacturers in 2024
 Figure 18. Global 5 and 10 Largest Subcutaneous Vaccine Adjuvants Players: Market Share by Revenue in Subcutaneous Vaccine Adjuvants in 2024
 Figure 19. Subcutaneous Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 20. Global Subcutaneous Vaccine Adjuvants Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 21. North America Subcutaneous Vaccine Adjuvants Sales Market Share by Country (2020-2031)
 Figure 22. North America Subcutaneous Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
 Figure 23. United States Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 24. Canada Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Europe Subcutaneous Vaccine Adjuvants Sales Market Share by Country (2020-2031)
 Figure 26. Europe Subcutaneous Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
 Figure 27. Germany Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 28. France Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. U.K. Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. Italy Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Russia Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Asia Pacific Subcutaneous Vaccine Adjuvants Sales Market Share by Region (2020-2031)
 Figure 33. Asia Pacific Subcutaneous Vaccine Adjuvants Revenue Market Share by Region (2020-2031)
 Figure 34. China Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 35. Japan Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. South Korea Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. India Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. Australia Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. China Taiwan Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Indonesia Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Thailand Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Malaysia Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Subcutaneous Vaccine Adjuvants Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Subcutaneous Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Subcutaneous Vaccine Adjuvants Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Subcutaneous Vaccine Adjuvants Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Subcutaneous Vaccine Adjuvants Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Subcutaneous Vaccine Adjuvants by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Subcutaneous Vaccine Adjuvants by Type (2020-2031)
 Figure 55. Global Subcutaneous Vaccine Adjuvants Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Subcutaneous Vaccine Adjuvants by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Subcutaneous Vaccine Adjuvants by Application (2020-2031)
 Figure 58. Global Subcutaneous Vaccine Adjuvants Price (US$/Unit) by Application (2020-2031)
 Figure 59. Subcutaneous Vaccine Adjuvants Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Samsung SD

SIMILAR REPORTS

Global Intramuscular Vaccine Adjuvants Market Research Report 2025
Global Oral Vaccine Adjuvants Market Research Report 2025
Global Biological Vaccines Adjuvants Market Research Report 2025
Immunostimulatory Adjuvants Market
Human Vaccine Adjuvants Market
Global Immune Adjuvant Market Research Report 2024
Global Noninvasive Delivery Vaccine Market Research Report 2025
Global Vaccine Particulate Adjuvants Market Research Report 2025
Global Adjuvant Therapy Market Research Report 2024
Veterinary Vaccine Adjuvants Market
Global Subcutaneous Injector Market Research Report 2025
Global Subcutaneous Drug Delivery Devices Market Insights Forecast to 2030
Subcutaneous Allergy Immunotherapies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Subcutaneous Medicine Delivery Devices Market Research Report 2024
Global Noninvasive Vaccination Market Research Report 2025
Global Non invasive Vaccine Market Research Report 2025
Global Subcutaneous Drug Delivery Equipment Market Research Report 2024
Global Mineral based Adjuvants Market Research Report 2024
Immune Globulin Subcutaneous Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Animal Vaccine Adjuvant Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions